Sanz-Ortiz J - Search Results

1

Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer.

Fariñas MC, Rodriguez-Valverde V, Zarrabeitia MT, Parra-Blanco JA, Sanz-Ortiz J. Fariñas MC, et al. Cancer. 1991 Sep 15;68(6):1279-84. doi: 10.1002/1097-0142(19910915)68:6<1279::aid-cncr2820680617>3.0.co;2-y. Cancer. 1991. PMID: 1873782

2

Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2.

Real PJ, Cao Y, Wang R, Nikolovska-Coleska Z, Sanz-Ortiz J, Wang S, Fernandez-Luna JL. Real PJ, et al. Cancer Res. 2004 Nov 1;64(21):7947-53. doi: 10.1158/0008-5472.CAN-04-0945. Cancer Res. 2004. PMID: 15520201

3

Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level.

Sanz Ortiz J. Sanz Ortiz J. Clin Transl Oncol. 2008 Aug;10(8):486-92. doi: 10.1007/s12094-008-0237-2. Clin Transl Oncol. 2008. PMID: 18667379 Review.

4

[The patient with cancer and his or her family].

Sanz Ortiz J. Sanz Ortiz J. Med Clin (Barc). 1991 May 18;96(19):745-6. Med Clin (Barc). 1991. PMID: 1875755 Spanish. No abstract available.

5

Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).

Rivera F, Vega-Villegas ME, López-Brea M, Isla D, Mayorga M, Galdós P, Rubio A, Del Valle A, García-Reija F, García-Montesinos B, Rodríguez-Iglesias J, Mayordomo J, Rama J, Saiz-Bustillo R, Sanz-Ortiz J. Rivera F, et al. Among authors: sanz ortiz j. Cancer Chemother Pharmacol. 2008 Jul;62(2):253-61. doi: 10.1007/s00280-007-0599-0. Epub 2007 Sep 28. Cancer Chemother Pharmacol. 2008. PMID: 17901953 Clinical Trial.

6

[Active oncologic treatment of advanced and terminal neoplastic disease].

Sanz Ortiz J, Rivera Herrero F, Ferré AJ, Vega Villegas ME. Sanz Ortiz J, et al. Med Clin (Barc). 2000 Mar 4;114(8):302-7. doi: 10.1016/s0025-7753(00)71276-0. Med Clin (Barc). 2000. PMID: 10774520 Review. Spanish. No abstract available.

7

Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.

Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Ramos FJ, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Mayorga M, Sanz-Ortiz J. Rivera F, et al. Clin Transl Oncol. 2007 Jan;9(1):40-7. doi: 10.1007/s12094-007-0008-5. Clin Transl Oncol. 2007. PMID: 17272229 Clinical Trial.

8

Protein energy malnutrition (PEM) in cancer patients.

Sanz Ortiz J, Moreno Nogueira JA, García de Lorenzo y Mateos A. Sanz Ortiz J, et al. Clin Transl Oncol. 2008 Sep;10(9):579-82. doi: 10.1007/s12094-008-0253-8. Clin Transl Oncol. 2008. PMID: 18796375

9

Chemotherapy at the end of life: up until when?

Sanz Ortiz J. Sanz Ortiz J. Clin Transl Oncol. 2012 Sep;14(9):667-74. doi: 10.1007/s12094-012-0847-6. Epub 2012 Jul 7. Clin Transl Oncol. 2012. PMID: 22855142

10

Informed consent and sedation.

Sanz-Ortiz J. Sanz-Ortiz J. Clin Transl Oncol. 2006 Feb;8(2):94-7. doi: 10.1007/s12094-006-0164-z. Clin Transl Oncol. 2006. PMID: 16632422 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page